News & Updates

Patients who are on obesity-related medications before undergoing bariatric surgery may be more likely to discontinue their medications and less likely to restart them after undergoing Roux-en-Y gastric bypass (RYGB) than laparoscopic sleeve gastrectomy (LSG), a recent study has shown.

Among patients who had previously undergone ablation for atrial fibrillation (AF), the risk of recurrent AF increased with rising body mass index (BMI), according to a study from Denmark presented at EHRA 2022.

Nondiabetic adults with overweight or obesity lost more weight when treated with once-weekly semaglutide than once-daily liraglutide, as demonstrated by results of the phase IIIb STEP* 8 trial.

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) can keep serum urate levels low in patients with and without diabetes, according to a recent Singapore study.

The use of either an insulin pump or a continuous glucose monitoring (CGM) device among pregnant women with type 1 diabetes leads to improved glycaemic control, although pump use appears to be linked to higher birth weight measures, a study has found.

Treatment with rosuvastatin, given at moderate and high intensity doses, as well as simvastatin and atorvastatin, given at high intensity doses, modestly reduce levels of nonhigh-density lipoprotein cholesterol (non-HDL-C) in diabetic patients over 12 weeks compared with placebo, a study has shown.

In children with type 1 diabetes (T1D), glycated haemoglobin A1c (HbA1c) significantly decreases at 12 months after diagnosis with the help of a technology-enabled, team-based approach to intensified new-onset education involving target setting, continuous glucose monitoring (CGM), and remote data review, results of a study have shown.

Individuals at elevated cardiovascular disease risk (overweight/obese, increased blood pressure levels) may improve the duration and efficiency of their sleep through regular resistance exercise regimens, according to a study presented at the EPI Lifestyle Scientific Sessions 2022.